| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRK | Common Stock | Options Exercise | $58,265 | +824 | +2% | $70.71 | 42,143 | 02 Feb 2024 | Direct | |
| transaction | MRK | Common Stock | Options Exercise | $2,371,894 | +32,170 | +76% | $73.73 | 74,313 | 02 Feb 2024 | Direct | |
| transaction | MRK | Common Stock | Sale | $6,420,349 | -50,694 | -68% | $126.65 | 23,619 | 02 Feb 2024 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | MRK | Stock Option (Right to Buy) | Options Exercise | $0 | -824 | -100% | $0.000000* | 0 | 02 Feb 2024 | Common Stock | 824 | $70.71 | Direct | F2 |
| transaction | MRK | Stock Option (Right to Buy) | Options Exercise | $0 | -32,170 | -59% | $0.000000 | 22,088 | 02 Feb 2024 | Common Stock | 32,170 | $73.73 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.4300 to $126.9000, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| F2 | The option vested and became exercisable in three equal installments on 10/30/2019, 10/30/2020 and 10/30/2021. |
| F3 | The option vests and becomes exercisable in three equal installments on 5/4/2022, 5/4/2023 and 5/4/2024. |